Of note, glial activation is not specific to AD pathophysiology, elevated blood GFAP levels could be observed in other neurological diseases (e.g., FTD, VaD), as our and other studies have shown [49–53]. The gene discussed is GFAP; the disease is frontotemporal dementia.